Catalyst Wire Dossier Catalyst Wire Dossier

Deferoxamine Mesylate

Deferoxamine · Fresenius Kabi USA, LLC
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Deferoxamine Mesylate, covering 2007-12-14 to 2024-02-05. Get the full timeline:

Most recent: FDA Approved: DEFEROXAMINE MESYLATE — Supplemental Application (Apotex Corp.)

See pricing